HealthEquity price target raised to $125 from $112 at Barrington

Barrington raised the firm’s price target on HealthEquity (HQY) to $125 from $112 and keeps an Outperform rating on the shares. The company’s Q1 topped expectations and its fiscal 2026 guidance was raised, the analyst tells investors in a research note. The firm says that with a “strong and industry-leading” health savings account business, combined with a higher effective yield on cash, HealthEquity’s operating and financial performance should continue to improve on a consolidated basis going forward.